Authors:
Pavletic, SZ
O'Dell, JR
Pirruccello, SJ
Ursick, MM
Haire, CE
Sharp, JG
Kessinger, A
Klassen, LW
Citation: Sz. Pavletic et al., Intensive immunoablation and autologous blood stem cell transplantation inpatients with refractory rheumatoid arthritis: The University of Nebraska experience, J RHEUMATOL, 28, 2001, pp. 13-20
Authors:
Kessinger, A
Mann, S
Murphy, BO
Jackson, JD
Sharp, JG
Citation: A. Kessinger et al., Circulating factors may be responsible for murine strain-specific responses to mobilizing cytokines, EXP HEMATOL, 29(6), 2001, pp. 775-778
Authors:
Demirkazik, A
Kessinger, A
Armitage, JO
Bierman, PJ
Lynch, J
Vose, J
Chan, W
Sharp, JG
Citation: A. Demirkazik et al., Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation, BONE MAR TR, 28(2), 2001, pp. 207-212
Authors:
Joshi, SS
Lynch, JC
Pavletic, SZ
Tarantolo, SR
Pirruccello, SJ
Kessinger, A
Bishop, MR
Citation: Ss. Joshi et al., Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics, BLOOD, 98(6), 2001, pp. 1963-1970
Authors:
Joshi, SS
Miller, K
Jackson, JD
Warkentin, P
Kessinger, A
Citation: Ss. Joshi et al., Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin plus G-CSF in cancer patients, CYTOTHERAPY, 2(1), 2000, pp. 15-24
Authors:
Joshi, SS
Tarantolo, SR
Kuszynski, CA
Kessinger, A
Citation: Ss. Joshi et al., Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer, CLIN CANC R, 6(11), 2000, pp. 4351-4358
Citation: A. Kessinger, Management of patients with cancer of unknown primary site - The Hainsworth/Greco article reviewed, ONCOLOGY-NY, 14(4), 2000, pp. 574-575
Authors:
Bishop, MR
Tarantolo, SR
Pavletic, ZS
Lynch, JC
Morris, ME
Zacharias, D
Armitage, JO
Kessinger, A
Citation: Mr. Bishop et al., Filgrastim as an alternative to donor leukocyte infusion for relapse afterallogeneic stern-cell transplantation, J CL ONCOL, 18(11), 2000, pp. 2269-2272
Authors:
Pavletic, ZS
Arrowsmith, ER
Bierman, PJ
Goodman, SA
Vose, JM
Tarantolo, SR
Stein, RS
Bociek, G
Greer, JP
Wu, CD
Kollath, JP
Weisenburger, DD
Kessinger, A
Wolff, SN
Armitage, JO
Bishop, MR
Citation: Zs. Pavletic et al., Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia, BONE MAR TR, 25(7), 2000, pp. 717-722
Authors:
Gordon, B
Lyden, E
Lynch, J
Tarantolo, S
Pavletic, Z
Bishop, M
Reed, E
Kessinger, A
Haire, W
Citation: B. Gordon et al., Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients, BONE MAR TR, 25(1), 2000, pp. 79-83
Authors:
Bishop, MR
Tarantolo, SR
Geller, RB
Lynch, JC
Bierman, PJ
Pavletic, ZS
Vose, JM
Kruse, S
Dix, SP
Morris, ME
Armitage, JO
Kessinger, A
Citation: Mr. Bishop et al., A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation, BLOOD, 96(1), 2000, pp. 80-85
Citation: A. Kessinger, Blood stem cell versus bone marrow transplantation - A critical appraisal, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 447-456
Authors:
Pirruccello, SJ
Page, CJ
Bishop, MR
Letheby, BA
Warkentin, PI
Jackson, JD
Kessinger, A
Citation: Sj. Pirruccello et al., Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique, CYTOTHERAPY, 1(4), 1999, pp. 279-286
Authors:
Tezcan, H
Vose, JM
Bast, M
Bierman, PJ
Kessinger, A
Armitage, JO
Citation: H. Tezcan et al., Limited stage I and II follicular non-Hodgkin's lymphoma: The Nebraska Lymphoma Study Group experience, LEUK LYMPH, 34(3-4), 1999, pp. 273-285
Authors:
Freeman, MB
Vose, JM
Bennett, CL
Anderson, JR
Kessinger, A
Turner, K
Pierson, J
Bishop, MR
Bierman, P
Armitage, JO
Citation: Mb. Freeman et al., Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995, BONE MAR TR, 24(6), 1999, pp. 679-684
Citation: Re. Steg et al., Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation, BONE MAR TR, 23(9), 1999, pp. 959-962
Authors:
Gordon, B
Tarantolo, S
Ruby, E
Stephens, L
Lynch, J
Kessinger, A
Haire, W
Citation: B. Gordon et al., Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation, BONE MAR TR, 22(10), 1998, pp. 999-1003